zacks.com

Lipocine (LPCN) delivered earnings and revenue surprises of -5.88% and +19.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Investors need to pay close attention to BBT stock based on the movements in the options market lately.

COCO, INDV and MPC stand out as momentum buys as investors apply Richard Driehaus' "buy high and sell higher" strategy.

NICE beats Q1 estimates as cloud revenue climbs 15% and AI demand surges, with shares rising in pre-market trading.

MKS stock jumps after Q1 earnings and revenue beat estimates, fueled by AI-related demand across semiconductor markets.

DASH Q1 results benefit from orders and Marketplace GOV, while revenue misses estimates and margins narrow.

PHG stock gains after Philips posts Q1 earnings, with 4% comparable sales growth and improved cash flow despite lower revenues.

Q1 earnings results are setting records, riding the AI trade to new heights.

Quantum ETFs are surging as breakthroughs, funding and AI demand fuel growth, offering diversified exposure to a high-risk, high-reward theme.

ADMA cuts its 2026 outlook after Q1 revenues slip amid IG market pressure, though Asceniv demand and margins stay strong.